The efficacy of switching intravenous to oral brivaracetam following status epilepticus: A real-world, multicenter Sicilian study
The switch of BRV from intravenous to oral administration has demonstrated a good effectiveness and safety profile in long-term treatment of epilepsy following a prior SE particularly in patients with vascular diseases.
Authors
- Leila Zummo (ORCID: https://orcid.org/0000-0003-0320-4570)
- Giovanni Tripepi (ORCID: https://orcid.org/0000-0002-3580-4602)
- Luigi Agrò
- Daniele Lo Coco (ORCID: https://orcid.org/0000-0002-4076-0843)
- G. Maira (ORCID: https://orcid.org/0000-0001-6008-9068)
- Salvatore Zappulla
- Francesco Lamanna (ORCID: https://orcid.org/0000-0002-0447-759X)
- Angelina Laganà
- P Laisa
- Lidia Urso (ORCID: https://orcid.org/0000-0002-9932-3226)
- Mariangela Panebianco (ORCID: https://orcid.org/0000-0001-8956-5486)
- Angelo Labate (ORCID: https://orcid.org/0000-0002-8827-7324)
- Chiara Martellino
- Giorgia Atanasio (ORCID: https://orcid.org/0009-0003-7179-5525)
- Orazio Pardeo
- Matilde Gammino
- R Avarello
- Giuseppe Salafica
- Attilio Vinaccia
- Diana Tilenni
Institutions
- University of Messina (IT)
- University of Ragusa (IT)
- Ospedale Vincenzo Cervello (IT)
- Nuovo Ospedale San Giovanni di Dio (IT)
- Ospedale Sant Antonio (IT)
- Ospedale Garibaldi (IT)
- Istituto di Fisiologia Clinica (IT)
- National Research Council (IT)
- Ospedali Riuniti Umberto I (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Epilepsy & Behavior
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1016/j.yebeh.2025.110744
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00